SARS-CoV-2 Genomic Diversity, Viral Proteins, and Clinical Symptoms Including Smell Loss

By

The study "SARS-CoV-2 population dynamics in immunocompetent individuals in a closed transmission chain shows genomic diversity over the course of infection" highlights that SARS-CoV-2 is not genetically static during infection. Even within a single infected individual, viral populations can accumulate mutations over time, creating a diverse collection of viral variants. Some of these mutations occur in proteins that influence viral replication, immune evasion, tissue tropism, and symptom development, potentially affecting disease severity and clinical manifestations such as loss of smell (anosmia).

Key SARS-CoV-2 Proteins and Their Functions

NSP5 (Non-Structural Protein 5)

Function:
NSP5, also known as the Main Protease (Mpro or 3CLpro), is essential for viral replication. It cleaves large viral polyproteins (pp1a and pp1ab) into functional proteins required for the virus to reproduce.

Importance:
Because NSP5 is indispensable for viral maturation, it has become a major target for antiviral therapies. Inhibiting NSP5 can effectively halt viral replication and reduce viral load.

ORF3a (Open Reading Frame 3a Protein)

Function:
ORF3a is a multifunctional accessory protein involved in:

  • Virus release from infected cells
  • Induction of apoptosis (programmed cell death)
  • Activation of inflammatory pathways
  • Modulation of host immune responses

Characteristics:
ORF3a functions as a viroporin (ion channel protein), altering cellular membranes and contributing to viral pathogenicity.

Role in Disease:
By promoting inflammation and facilitating viral spread, ORF3a may contribute to tissue damage in the respiratory tract and nervous system, potentially influencing symptoms such as fatigue, headache, and smell dysfunction.

ORF6 (Open Reading Frame 6 Protein)

Function:
ORF6 is a potent antagonist of the host immune response.

Mechanism:
It blocks the nuclear transport of proteins required for interferon signaling, weakening one of the body's most important antiviral defense systems.

Significance:
This immune suppression allows SARS-CoV-2 to establish infection more efficiently and may prolong viral persistence, creating opportunities for additional viral evolution within the host.

N Protein (Nucleocapsid Protein)

Function:
The Nucleocapsid (N) protein binds and packages the viral RNA genome into new viral particles.

Major Roles:

  • RNA binding and protection
  • Viral genome replication and transcription
  • Virus assembly and packaging
  • Regulation of host immune responses

Diagnostic Importance:
Because the N protein is abundant and highly immunogenic, it is commonly used as a target in diagnostic and serological tests.

Smell Loss (Anosmia) and SARS-CoV-2 Infection

One of the most distinctive symptoms of COVID-19 is the sudden loss or reduction of smell (anosmia or hyposmia).

How SARS-CoV-2 Causes Smell Loss

Unlike many respiratory viruses that cause smell loss through nasal congestion alone, SARS-CoV-2 can directly affect the olfactory system.

Research suggests that:

  • The virus infects supporting (sustentacular) cells within the olfactory epithelium.
  • Infection triggers local inflammation and immune activation.
  • Damage to the olfactory environment disrupts signaling from smell receptor neurons.
  • In some cases, inflammation may extend to olfactory nerve pathways and central nervous system structures involved in smell perception.

Relationship to Viral Proteins

Several viral proteins may contribute indirectly to smell loss:

  • ORF3a promotes inflammation and cellular stress, which may increase damage within the olfactory epithelium.
  • ORF6 suppresses antiviral immune responses, potentially allowing more extensive infection of olfactory tissues.
  • N Protein may influence host immune signaling and inflammatory responses.
  • NSP5 supports viral replication, increasing viral burden in susceptible tissues.

Genomic Diversity and Smell Loss

The genomic diversity observed in the referenced study suggests that viral populations can evolve during infection. Mutations arising in accessory proteins such as ORF3a, ORF6, NSP5, or N may alter:

  • Viral replication efficiency
  • Tissue targeting (tropism)
  • Immune evasion
  • Inflammatory responses

These changes could help explain why some individuals experience profound smell loss while others do not, even when infected with closely related viral strains.

Clinical Symptoms of COVID-19

Symptoms typically appear 2–14 days after exposure and range from mild to severe.

Common Symptoms

  • Fever or chills
  • Cough
  • Shortness of breath
  • Fatigue
  • Muscle or body aches
  • Headache
  • Sore throat
  • Congestion or runny nose
  • Nausea or vomiting
  • Diarrhea
  • New loss of smell (anosmia)
  • New loss of taste (ageusia)

Severe Symptoms

  • Severe difficulty breathing
  • Persistent chest pain or pressure
  • New confusion
  • Inability to stay awake
  • Bluish lips or face
  • Low oxygen saturation

Less Common Symptoms

  • Skin rash
  • Discoloration of fingers or toes
  • Red or irritated eyes
  • Dizziness
  • Palpitations

Asymptomatic Infection

Some individuals remain completely asymptomatic despite carrying and transmitting SARS-CoV-2. The study's findings suggest that viral evolution can occur even in immunocompetent individuals with varying symptom severity.

Long COVID and Persistent Smell Loss

Some individuals experience symptoms that persist for months after the acute infection.

Common Long COVID manifestations include:

  • Fatigue
  • Brain fog
  • Difficulty concentrating
  • Memory problems
  • Joint pain
  • Chest pain
  • Sleep disturbances
  • Heart palpitations
  • Anxiety or depression
  • Dizziness
  • Persistent loss or distortion of smell (anosmia/parosmia)
  • Persistent loss of taste

Persistent smell dysfunction is among the most frequently reported neurological symptoms of Long COVID and may result from prolonged inflammation, incomplete regeneration of olfactory tissues, or persistent immune dysregulation following infection.

Conclusion

The study demonstrates that SARS-CoV-2 continues to diversify genetically during infection, even in immunocompetent individuals. Mutations arising in proteins such as NSP5, ORF3a, ORF6, and the N protein may influence viral replication, immune evasion, inflammation, and tissue-specific effects. These processes may contribute to the wide range of COVID-19 symptoms, including the characteristic loss of smell, as well as the persistent neurological symptoms observed in Long COVID.

Explained by Robert Sapolsky: Smell Loss
https://www.youtube.com/watch?v=w_yUYqOblO4&t=922s

© 2000-2030 Sieglinde W. Alexander. All writings by Sieglinde W. Alexander have a five-year copyright. Library of Congress Card Number: LCN 00-192742 ISBN: 0-9703195-0-9


Comments

Post a Comment

Popular posts from this blog

Schnitzler Syndrome: A Rare Autoinflammatory Disorder

By
Schnitzler syndrome is a rare, chronic autoinflammatory disease characterized by chronic urticaria (hives), recurrent fever, joint pain, and monoclonal gammopathy (abnormal proteins in the blood). First described by Dr. Liliane Schnitzler in 1972 , this condition is often misdiagnosed, leading to years of untreated symptoms before a correct diagnosis is made. The case report, " A 58-Year-Old Woman With Urticaria, Fever, and Joint Pain " , describes a case that closely aligns with my own experience with this challenging disorder. Key Features of Schnitzler Syndrome Schnitzler syndrome presents with a characteristic set of symptoms, though not all patients experience them in the same way: Chronic Urticaria (Hives) – Persistent, non-itchy or mildly itchy red patches that do not respond to antihistamines. Monoclonal Gammopathy (IgM or IgG type) – Abnormal monoclonal immunoglobulin detected in the blood (most commonly IgM ). Recurrent Fever – Unexplained fever episodes, often...
Read more

Acute Flaccid Myelitis (AFM): Understanding the “Polio-like” Illness Affecting the Spinal Cord

By
Acute flaccid myelitis (AFM) is a rare but serious neurological disorder that primarily affects children and results in sudden weakness or paralysis in the limbs. Often referred to as a “polio-like” illness, AFM has drawn growing attention over the past decade due to its similarities with poliomyelitis and its seasonal spikes in reported cases. While AFM remains uncommon, its potential severity—and the uncertainty surrounding its causes—make it an important condition for clinicians, parents, and public health officials to understand. What Is Acute Flaccid Myelitis? AFM is a condition that affects the gray matter of the spinal cord , where it damages motor neurons responsible for muscle movement. This leads to acute, flaccid paralysis , meaning muscles become limp and weak, often without warning. The condition can progress rapidly, and in some cases, the weakness can become long-lasting or even permanent. Although its symptoms resemble those of poliovirus infection, AFM is not cau...
Read more

Dysferlin Protein: Key Roles, Genetic Locations

By
Image
The purpose of this article is to share and discuss the details of a new discovery, which is highlighted within: CRISPR-Cas9: A Breakthrough Tool to Repair the DYSF Gene The dysferlin protein plays an essential role in maintaining the integrity of muscle cell membranes, particularly in tissues that endure significant mechanical stress, such as skeletal and cardiac muscles . Encoded by the DYSF gene , dysferlin is indispensable for repairing damaged cell membranes after injury caused by muscle contraction or external forces. This article explores the main locations where dysferlin is produced, its role in muscle repair, and supportive nutritional and therapeutic strategies for individuals with dysferlin deficiency, such as those affected by dysferlinopathies (e.g., Limb-Girdle Muscular Dystrophy Type 2B or Miyoshi Myopathy). Currently, there is no definitive answer as to why the severity of dysferlin protein expression or depletion varies. Do pathogens play a role in the methylation o...
Read more

Very Long-Chain Fatty Acids (VLCFAs) X-ALD and Spinal Muscular Atrophy (SMA): Exploring the Connection

By
Image
Introduction: White Brain Matter, VLCFAs, and X-ALD X-linked Adrenoleukodystrophy (X-ALD) is a rare inherited metabolic disorder and a major cause of progressive neurodegeneration in children—sometimes referred to as “childhood dementia.” Across related conditions, prevalence can range from approximately 1 in 2,000 to 1 in 500,000 newborns. Among its forms, childhood cerebral X-ALD is the most severe, marked by rapid inflammatory demyelination in the brain and often fatal outcomes if not treated early. At the core of X-ALD is a disruption in the metabolism of Very Long-Chain Fatty Acids (VLCFAs). Normally, these fatty acids are broken down in peroxisomes—specialized structures within cells that help maintain metabolic balance. In X-ALD, a mutation in the ABCD1 gene impairs this function, causing VLCFAs to accumulate, particularly in the white matter of the brain, spinal cord, and adrenal glands. This accumulation leads to demyelination, adrenal insufficiency (Addison’s disease), an...
Read more

Toxic Skin Condition Post-mRNA COVID-19 Vaccination

By
Image
Important update: My experiences have now been formally verified following several years of dismissal. Vasculitis syndromes: the pathogenic roles of COVID-19 and related vaccinations https://link.springer.com/article/10.1186/s12985-025-03032-x  ----------------------------------------- Identifying Severe Skin Conditions Post-Vaccination Following administration of the BioNTech mRNA vaccine, a small subset of individuals may develop severe and complex reactions. These reactions are often misdiagnosed or misunderstood due to their rarity and diverse presentation. This essay examines a case characterized by severe skin conditions, systemic symptoms, and complications such as hypercalcemia and crystal formation. It highlights the need for accurate diagnosis, holistic management, and increased awareness of these rare but significant vaccine-related adverse events. Initial Symptoms and Misdiagnoses Severe symptoms began shortly after the first dose of the BioNTech vaccine, initially pres...
Read more

Is ME CFS connected to Spinal Muscular Atrophy (SMA) or Post Polio?

By
Today, I understand why Spinal Muscular Atrophy (SMA) received little attention, particularly in the mid-50s. This complex and debilitating genetic illness was poorly understood, and patients' symptoms were often minimized or even dismissed. For more information, please visit the Spinal Muscular Atrophy (SMA) page on MalaCards . Even now, many neurologists lack detailed knowledge of SMA, and comprehensive examinations mentioned in research are rarely pursued. In 2008, while investigating permanent adrenal insufficiency, an MRI ordered by my endocrinologist unexpectedly revealed Chiari Malformation II. However, surgery in 2009 brought no improvement. In 2010, a DNA test showed a genetic marker in the ACTN3 gene: https://www.malacards.org/search/results?q=ACTN3%20gene%20and%20Spinal%20Muscular%20Atrophy%20(SMA) A 2015 MRI revealed ankylosing spondylitis, multiple Tarlov cysts, stenosis at L4 and L5, spinal canal narrowing, and widespread degenerative changes. Surgery on L4 and L5 ...
Read more

Polio and Post-Polio Syndrome (PPS): Summary and Key Insights

By
Image
  Abstract To investigate the possible role of poliovirus (PV) infection in the development of Post-Polio Syndrome (PPS), researchers studied serum, cerebrospinal fluid (CSF), peripheral blood lymphocytes, and muscle tissue from 47 PPS patients. Elevated IgM antibodies against poliovirus were identified in a subset of patients, with titers reaching 1:250 compared with less than 1:50 in healthy individuals and disease controls. Using polymerase chain reaction (PCR) techniques targeting the poliovirus replicase gene, PV RNA sequences were detected in peripheral blood lymphocytes from 7 of 37 patients and in the CSF of 4 of 40 patients, while no viral sequences were detected in controls. Sequencing confirmed a 99.3% homology with poliovirus type 1. These findings suggest that some PPS patients may exhibit an ongoing immune response to poliovirus antigens. The detection of poliovirus RNA raises the possibility of persistent mutated virus or defective viral particles. However, the signi...
Read more

Cytokine Storm, Mast Cell Activation Syndrome (MCAS), Endothelial Dysfunction and microclots/thrombosis?

By
Update: New Research Builds on Previous Findings Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2832234?utm_source=silverchair&utm_medium=email&utm_campaign=article_alert-jamanetworkopen&utm_content=wklyforyou&utm_term=040925&adv= Conclusions: This recent cohort study builds upon earlier work by identifying COVID-related cytokine storm (COVID-CS) through common inflammation markers and comparing it with two other cytokine storm (CS) conditions: malignancy-associated hemophagocytic lymphohistiocytosis (MN-HLH) and CAR-T–associated cytokine release syndrome (CAR-T CRS) . Among the three groups, patients treated with CAR-T therapy showed the highest survival rates , in contrast to those with COVID-CS and MN-HLH. Interestingly, the study found that CAR-T CRS and COVID-CS share similar cytokine activation pathways , suggesting a comparable immune response mechanism. In c...
Read more

Introduction to Adenosine and Tachycardia

By
What is Adenosine? Adenosine is a chemical found in human cells, existing in three forms: adenosine, adenosine monophosphate (AMP), and adenosine triphosphate (ATP). Adenosine is a chemical found in the body that plays many roles, including influencing heart rate and promoting sleep and relaxation. It is also used as a medication to manage certain types of tachycardia, particularly supraventricular tachycardia. Adenosine works by slowing the heart rate through its action on the cardiac tissue. Adenosine production in the body occurs through multiple pathways: Phosphorylation of Adenine: Adenine can be directly phosphorylated to form AMP (adenosine monophosphate), which is then converted to ATP, ADP, and finally adenosine through dephosphorylation reactions. Breakdown of ATP: Adenosine is primarily formed in the body through the breakdown of ATP, which releases energy. ATP can be dephosphorylated stepwise through the action of various enzymes: ATP is first converted to ADP (adeno...
Read more

The Impact of Acids on Muscular and Vascular Systems: Potential Negative Outcomes

By
This is ongoing research, and updates will be included as soon as they become available. Acids, whether from external sources (like industrial chemicals) or internal imbalances (such as metabolic disorders), can have profound effects on both the muscular and vascular systems.   Exposure to strong acids or acid imbalances in the body can disrupt cellular function, cause tissue damage, and lead to systemic health problems. This article explores how acids can negatively impact muscular and vascular health, with an emphasis on both external exposure to corrosive acids and internal acid imbalances caused by metabolic disorders or genetic conditions. Since not everyone is affected by ME/CFS or COVID, it could be beneficial to test for genetic predispositions, such as amino acids, particularly fatty acids. 1. External Acid Exposure and Its Effects on Muscular and Vascular Systems 1.1. Muscular Effects Muscle tissue is highly sensitive to changes in pH, and exposure to strong acids ca...
Read more